<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id><journal-title-group><journal-title>BMC Public Health</journal-title></journal-title-group><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786534</article-id><article-id pub-id-type="publisher-id">21648</article-id><article-id pub-id-type="doi">10.1186/s12889-025-21648-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association between life's essential 8 and Parkinson's disease: a case&#x02013;control study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Fan</surname><given-names>Jiaxin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Yanfeng</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Xingzhi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Shuai</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhan</surname><given-names>Shuqin</given-names></name><address><email>sqzhan@mail.xjtu.edu.cn</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Rui</given-names></name><address><email>rli@nwpu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/009czp143</institution-id><institution-id institution-id-type="GRID">grid.440288.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 0451</institution-id><institution>Department of Geriatric Neurology, </institution><institution>Shaanxi Provincial People&#x02019;s Hospital, </institution></institution-wrap>No. 256 West Youyi Road, Xi&#x02019;an, 710068 China </aff><aff id="Aff2"><label>2</label>Shaanxi Provincial Clinical Research Center for Geriatric Medicine, Xi&#x02019;an, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03aq7kf18</institution-id><institution-id institution-id-type="GRID">grid.452672.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 5804</institution-id><institution>Department of Neurology, </institution><institution>The Second Affiliated Hospital of Xi&#x02019;an Jiaotong University, </institution></institution-wrap>No. 157 West Five Road, Xi&#x02019;an, 710004 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/009czp143</institution-id><institution-id institution-id-type="GRID">grid.440288.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1758 0451</institution-id><institution>Department of Oncology Surgery, </institution><institution>Shaanxi Provincial People&#x02019;s Hospital, </institution></institution-wrap>Xi&#x02019;an, China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01dyr7034</institution-id><institution-id institution-id-type="GRID">grid.440747.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0473 0092</institution-id><institution>Department of Clinical Laboratory, </institution><institution>Affiliated Hospital of Yan&#x02019;an University, </institution></institution-wrap>Yan&#x02019;an, China </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01y0j0j86</institution-id><institution-id institution-id-type="GRID">grid.440588.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0307 1240</institution-id><institution>Institute of Medical Research, </institution><institution>Northwestern Polytechnical University, </institution></institution-wrap>Xi&#x02019;an, China </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04j1qx617</institution-id><institution-id institution-id-type="GRID">grid.459327.e</institution-id><institution>Department of Orthopedics, </institution><institution>Civil Aviation General Hospital, </institution></institution-wrap>Beijing, China </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>411</elocation-id><history><date date-type="received"><day>23</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">Life's essential 8 (LE8) is an emerging approach for accessing and quantifying cardiovascular health (CVH), but the effect on Parkinson's disease (PD) is still unclear. This study aimed to elucidate the association between LE8 metrics and PD in the US adults.</p></sec><sec><title>Methods</title><p id="Par2">Data of 26,975 participants were extracted from the last 7 National Health and Nutrition Examination Survey (NHANES) cycles (2005&#x02013;2018). The LE8 metrics were calculated according to the American Heart Association criterion, and participants were divided into 3 groups using tertile range. Multivariate logistic regression models were constructed to explore the association between LE8 metrics and PD. Sensitivity analysis was conducted to verify robustness. A nonlinear linkage was evaluated via restricted cubic spline (RCS). The stability of this effect was validated by subgroup analysis and interaction test.</p></sec><sec><title>Results</title><p id="Par3">A total of 26,975 eligible participants (including 271 PD cases and 26,704 non-PD cases) were included in this study. The multivariate logistic regression models revealed a reverse association of continuous LE8 metrics with PD with ORs of 0.97 (unadjusted model [95% CI: 0.96&#x02013;0.98, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01], partially adjusted model [95% CI: 0.97&#x02013;0.98, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01], fully adjusted model [95% CI: 0.95&#x02013;0.98, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01]). Compared to those of low group, the ORs for high group were 0.37 (95% CI: 0.27&#x02013;0.50, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) in unadjusted model, 0.51 (95% CI: 0.36&#x02013;0.72, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) in partially adjusted model, and 0.51 (95% CI: 0.32&#x02013;0.81, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) in fully adjusted model. The sensitivity analysis ensured the robustness of the observed LE8-PD association. A nonlinear relationship (<italic>P</italic>
<sub>nonlinearity</sub>&#x02009;&#x0003c;&#x02009;0.01) was observed via RCS analysis. The subgroup analysis showed that participants'gender might impact the strength of LE8 metrics-PD association (<italic>P</italic>
<sub>interaction</sub>&#x02009;=&#x02009;0.029).</p></sec><sec><title>Conclusions</title><p id="Par4">CVH, as delineated by LE8 metrics, was reversely associated with PD in the dose&#x02013;response pattern, more pronounced in female compared to male. These findings highlight the potential of the LE8 metrics to guide targeted strategies for addressing gender-based CVH disparities, offering beneficial insights for the tertiary prevention of PD.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12889-025-21648-0.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Life's essential 8</kwd><kwd>Cardiovascular health</kwd><kwd>Parkinson's disease</kwd><kwd>NHANES</kwd><kwd>Beneficial insight</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Parkinson's disease (PD) is the second frequent neurodegenerative condition, presenting a slow deterioration with functional independence and quality of life for affected individuals [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The number of global PD patients has reached about 6.1 million in 2016, which is projected to increase to 10 million by 2030 [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The incidence of PD patients increases 5&#x02013;10 folds in the sixth to the ninth decades of life course, and the ageing of the global population makes this trend even more pronounced [<xref ref-type="bibr" rid="CR5">5</xref>]. Along with this increase, the familial and societal economic burdens of PD have also escalated. In addition to classical motor symptoms such as bradykinesia, rigidity with cogwheeling, rest tremor, and postural abnormality, many patients develop a succession of nonmotor symptoms, including sleep disturbances, neuropsychiatric disorders, and cognitive impairment. Nonmotor symptoms can antedate or delay the onset of motor symptoms, increasing in severity with disease duration. Dopaminergic drugs and functional neurosurgery remain the two cornerstones of PD treatment. However, these approaches neglect the conspicuous heterogeneity of afflicted individuals and cannot arrest the progression of PD. Considering that genetic, environmental, and lifestyle dysfunctions are the etiologies of PD, a promising shift from a focus solely on disease treatment to intervening the modifiable risk factors (including sleep, diet, and physical activity) is urgently needed for burden-relieving potential.
</p><p id="Par6">During the search to investigate the risk factors of PD, a vast array of studies supports that there are several common factors between PD and cardiovascular disease (CVD), which may be attributed to the common pathogenesis of both diseases, such as oxidative stress, inflammation, and lipid metabolism [<xref ref-type="bibr" rid="CR6">6</xref>]. However, whether treating these shared cardiovascular risk factors affects the occurrence and progression of PD remains controversial. As a quantification of CVD, cardiovascular health (CVH) was first established and anchored on 7 health components in 2010. The ideal CVH consists of a well-balanced diet, physical activity, no smoking, normal body mass index (BMI), normal glucose, normal total cholesterol, and normal blood pressure, and is also known as &#x0201c;Life's Simple 7&#x0201d; (LS7) [<xref ref-type="bibr" rid="CR7">7</xref>]. Over time some indicators of LS7 may not provide a comprehensive appreciation of health behaviors and clinical practices in the contemporary environment, especially dietary components [<xref ref-type="bibr" rid="CR8">8</xref>]. In addition, subsequent evidence highlights that sleep health also contributes to risks for health outcomes [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. To address those limitations of LS7, the American Heart Association (AHA) proclaimed an improved algorithm&#x02014;&#x02014;&#x0201c;Life's essential 8&#x0201d; (LE8) to measure and prompt CVH, which is a powerful health trajectory system with enhanced sensitivity to interindividual and intraindividual changes over time [<xref ref-type="bibr" rid="CR8">8</xref>]. When all components of LE8 (including added sleep health and updated 7 parts of LS7) are at ideal levels, individuals will be more inclined to obtain favorable effects on CVH promotion. The optimal CVH is not only linked to lower CVD mortality, greater longevity, and better quality of life, but also associated with lower risks of non-CVD diseases, such as cancer, chronic obstructive pulmonary disease, and dementia [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. To date, much of the existing research has focused on separate effect of each part of the LE8 on PD, and there is a paucity of evidence objectively assessing the association of the LE8 with PD. The application of LE8 metrics enables a more precise evaluation of individual PD changes from a holistic perspective, we thus assume that the integrated effect conferred by optimal CVH on preventing PD may be greater than the sum of its parts.</p><p id="Par7">In the present study, from the perspective of newly published LE8 metrics as an evaluation of CVH, we investigated the association between LE8 metrics and PD in nationally representative data of United States (US) adults.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study strategy and participants</title><p id="Par8">As a comprehensive, flexible, stratified sampling program on the US population' health and nutritional status, National Health and Nutrition Examination Survey (NHANES) data had been collected and released biennially without disruption since 1999 [<xref ref-type="bibr" rid="CR13">13</xref>]. The trained staff gathered dietary, socioeconomic, demographic, anthropometric, laboratorial, and clinical information via face-to-face household interviews and mobile examination centers. Due to the COVID-19 pandemic, the NHANES suffered from&#x02009;&#x0003e;&#x02009;1 year gap in data collection [<xref ref-type="bibr" rid="CR14">14</xref>]. And sleep health data in LE8 metrics were initially collected in 2005 [<xref ref-type="bibr" rid="CR15">15</xref>]. Thus, we actually used publicly available NHANES data from 2005 to 2018, spanning 7 cycles. Among the 101,316 participants recruited in NHANES 1999&#x02013;2018, 42,112 participants who were&#x02009;&#x0003c;&#x02009;18 years old were excluded firstly, 1,670 pregnant women were excluded. Next, 87 participants who did not know if they had been diagnosed with PD. Then, 30,472 participants with incomplete data of LE8 metrics were excluded, specifically, 2,150 participants were missing 1 item, 1,068 participants were missing 2 items, 111 participants were missing 3 items, 13 participants were missing 4 items, and 27,130 participants were completely missing 8 items. Ultimately, 26,975 eligible participants (including 271 PD cases and 26,704 non-PD cases) were included. The NCHS Ethics Review Board had approved this survey and the informed consents of all participants were signed. Considering the attributes of open access and deidentification, this study was exempted from the ethical approval of the Shaanxi Provincial People's Hospital Ethics Committee. The screening process and study strategy were showed in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Study strategy and screening process of this study. NHANES, National Health and Nutrition Examination Survey; PD, Parkinson's disease; LE8, Life's essential 8; VIF, Variance Inflation Factor</p></caption><graphic xlink:href="12889_2025_21648_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Assessment of PD</title><p id="Par9">Following previous methodology, participants were assessed PD depended on the use of specific medications to treat PD in NHANES database, which was proven to be the best available approach for identifying PD cases [<xref ref-type="bibr" rid="CR16">16</xref>]. In this sense, once a participant was reported to actively take any secure anti-PD medication, such as levodopa, methyldopa, carbidopa, entacapone, or pramipexole, he/she was considered to have PD [<xref ref-type="bibr" rid="CR17">17</xref>]. Conversely, if a participant was not reported to use any of the aforementioned medications, he/she was categorized as not having PD.</p></sec><sec id="Sec5"><title>Ascertainment of covariates</title><p id="Par10">The continuous covariates consisted of age, physical activity (PA), and laboratory-reported indicators, such as total cholesterol (TC), high-density lipoprotein (HDL), glycated hemoglobin (HbA1c), blood urea nitrogen (BUN), alanine transaminase (ALT), and aspartate aminotransferase (AST). The categorical covariates included: 1) Gender was classified as female and male; 2) Ethnicity was divided into 4 groups: Mexican American, Non-Hispanic Black, Non-Hispanic White, and Other Race; 3) Educational level was categorized into&#x02009;&#x0003c;&#x02009;High School, High School,&#x02009;&#x0003e;&#x02009;High School; 4) Poverty-to-income ratio (PIR) was applied to evaluate socioeconomic condition, which was divided into&#x02009;&#x0003c;&#x02009;1.3, 1.3&#x02009;&#x02264;&#x02009;PIR&#x02009;&#x0003c;&#x02009;3.5, and&#x02009;&#x02265;&#x02009;3.5; 5) Marital status was categorized into unpartnered and partnered; 6) BMI was divided into&#x02009;&#x0003c;&#x02009;24 kg/m<sup>2</sup> and&#x02009;&#x02265;&#x02009;24 kg/m<sup>2</sup>; 7) Alcohol drinking was categorized into 5 strata: none, former, light, moderate, and heavy; 8) Smoking status was divided into never, former, and current; 9) Participants'medical history pertaining to CVD, diabetes mellitus (DM), hypertension, and stroke were diagnosed through related-drug treatment, self-reporting, combined with index measurements.</p></sec><sec id="Sec6"><title>Measurement of LE8 metrics</title><p id="Par11">The LE8 metrics, a novel tool for gauging CVH, were a combination of 4 health behaviors and 4 health factors. The thorough scoring algorithm of each LE8 component was consistent with previous methods [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. The integrated LE8 metrics were calculated relied on the unweighted average of each component's score (0&#x02013;100 scale). We analyzed the continuous LE8 metrics adherence to tertile ranges through the following steps: (1) Sorting: Data from 26,975 eligible participants were arranged in ascending order based on LE8 metrics, and the distribution of LE8 metrics was presented using a histogram (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A), density plot (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B), and boxplot (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C). The LE8 metrics followed a nearly normal distribution, ranging from 0 to 100, with no extreme values observed. (2) Defining cut-off points: Tertile thresholds were determined, with the first tertile corresponding to the 33.3rd percentile of LE8 metrics and the second tertile to the 66.7th percentile. (3) Grouping: The data were divided into three groups based on the thresholds: low (0&#x02009;&#x0003c;&#x02009;LE8&#x02009;&#x02264;&#x02009;60.0), moderate (60.0&#x02009;&#x0003c;&#x02009;LE8&#x02009;&#x02264;&#x02009;73.0), and high (73.0&#x02009;&#x0003c;&#x02009;LE8&#x02009;&#x02264;&#x02009;100.0), using the low group as the reference. Figure <xref rid="Fig2" ref-type="fig">2</xref>D presented the details of LE8 metrics grouping. For the 4 health behaviors, data on sleep patterns, nicotine exposure, and physical activity were derived from standardized questionnaires, while dietary data were determined by alternative Healthy Eating Index 2015 base on two 24-h dietary recalls [<xref ref-type="bibr" rid="CR20">20</xref>]. Information on BMI, blood glucose, blood pressure, and non-HDL cholesterol levels among the 4 health factors were procured laboratory and physical examinations at specialized mobile centers complying with established protocols and computational formulas.<fig id="Fig2"><label>Fig. 2</label><caption><p>The distribution and grouping of LE8 metrics. The histogram of LE8 metrics (<bold>A</bold>). The density plot of LE8 metrics (<bold>B</bold>). The boxplot of LE8 metrics (<bold>C</bold>). The details of LE8 metrics based on tertile grouping (<bold>D</bold>). LE8, Life's essential 8</p></caption><graphic xlink:href="12889_2025_21648_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par12">Using R software (4.2.3 version) and EmpowerStats (4.0 version) for Windows, we carried out the graphics and analyzed the data. Following the authoritative recommendations from the NCHS [<xref ref-type="bibr" rid="CR21">21</xref>], the appropriate sample weights were conducted to account for the oversampling, nonresponse, sampling error, and poststratification, making the estimates more nationally representative of the US adults [<xref ref-type="bibr" rid="CR22">22</xref>]. Briefly, sampling weights were calculated based on adjusted response rates and selection probabilities. Specifically, data from NHANES 2005&#x02013;2018 (7 cycles) were weighted using the 7-period Full Sample 2-Year MEC Exam Weight (WTMEC2YR), with the adjusted weight calculated as WTMEC2YR&#x02009;&#x000d7;&#x02009;1/7. To reflect the survey's complex design, the analysis incorporated strata (SDMVSTRA) and clusters (SDMVPSU), improving the precision and reliability of variance estimates. These techniques were implemented to minimize variability and ensure unbiased results. The weighted mean&#x02009;&#x000b1;&#x02009;standard error (SE) was used to outline the continuous variables, and the weighted percentage (%)&#x02009;&#x000b1;&#x02009;SE was used to outline the categorical variables. Differences among the low, moderate, and high groups were assessed by weighted ANOVA and weighted chi-square test. The Variance Inflation Factor (VIF) analysis was used to evaluate the collinearity among variables.</p><p id="Par13">To address missing values in our variables, we utilized the "mice" package in R to conduct Multiple Imputations (MIs), a well-established rule-of-thumb method for handling missing data [<xref ref-type="bibr" rid="CR23">23</xref>]. The process involved the following steps: (1) Identify missing data patterns: We calculated the missing rates for all variables and visualized the distribution of missing values using bar plots (Figure S1). This facilitated interpretation of the missingness patterns, such as Missing at Random (MAR) or Not Missing at Random (NMAR). (2) Generate imputed datasets: Using predictive mean matching (pmm), we handled the missing values by generating 10 separate imputed datasets (dataset 1&#x02013;10) with the Multiple Imputation by Chained Equations (MICE) function. Each dataset imputed missing values through predictive models that leverage the relationships among observed variables. (3) Fit statistical models on each dataset: Statistical models were fitted individually to each imputed dataset. We conducted rigorous sensitivity analyses to evaluate the robustness of the findings and to validate the effectiveness of the imputation approach in addressing missing data. (4) Synthesize results across datasets: The results obtained from the 10 imputed datasets were synthesized into comprehensive estimates and confidence intervals. This step accounted for the variability introduced by the imputation process, ensuring statistically robust and credible conclusions [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. Table S1 showed the overview of missing values of each variable. And Table S2 presented the missing values distribution by LE8 tertile grouping. Table S3 displayed the descriptive statistics of each variable before and after MIs. Following a previously reported threshold screening method [<xref ref-type="bibr" rid="CR25">25</xref>], we retained variables with missing rates&#x02009;&#x0003c;&#x02009;10%. Consequently, the PA variable, with a missing rate exceeding 10%, was removed from subsequent analyses.</p><p id="Par14">The association between LE8 metrics and PD were examined using multivariate logistic regression models, and 2 adjusted models were performed to evaluate the sensitivity and robustness of this effect. Specifically, no adjustment was made for the covariates in Model 1, while Model 2 (partially adjusted model) was augmented model by adjusting for age, gender, ethnicity, education level, marital status and PIR. Model 3 (fully adjusted model) further adjusted for BMI, ALT, AST, HbA1c, BUN, HDL, TC, smoking status, alcohol drinking, CVD, DM, stroke, and hypertension on the basis of Model 2, strengthening the adjustment of confounding covariates. Through the above constructed models, we fetched odds ratio (OR) and 95% confidence interval (95% CI) across the whole LE8 metrics groups. Moreover, we also calculated the ORs for each of the 10 imputed datasets and combined them into an overall estimate. To evaluate the potential impact of PA removal on the association of LE8 metrics and PD, we performed a similar reanalysis on the datasets without PA variable. These results were visualized using a forest plot to facilitate comparison and interpretation.</p><p id="Par15">Restricted cubic spline (RCS) plots with 4 knots were constructed to explore the potential nonlinear relationship between LE8 metrics and PD, using the "rms" package in R. The knots were automatically positioned at the 5th, 35th, 65th, and 95th percentiles of the independent variable, LE8. By selecting 4 knots, the fitted model in this study effectively balanced the risks of underfitting and overfitting, providing reliable and interpretable results. Additionally, subgroup analysis was stratified by covariates vulnerable to demographic discrepancies, which was used to assess the stability of the findings. An interaction test was also performed, with the <italic>P</italic> value for interaction used to quantify whether there was a significant interaction effect between two or more independent variables, using forest plot to visualize this process. Statistical significance was denoted at <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>General characteristics of participants</title><p id="Par16">A total of 26,975 participants were eligible in this study. From Table S1 and Figure S1A, we calculated the missing rate of each variable: 31.54% for PA, 7.73% for PIR, 6.75% for alcohol drinking, 0.65% for AST, 0.60% for ALT, 0.36% for BUN, 0.11% for stroke, 0.07% for HbA1c, 0.07% for education level, and 0.01% for CVD. Table S2 and Figure S1B presented the missing data distribution by LE8 tertile grouping. Table <xref rid="Tab1" ref-type="table">1</xref> listed the general characteristics of 26,975 participants by LE8 metrics category. Compared with those in low and moderate groups, the participants in high group were younger, more likely to be female, and Non-Hispanic White. Participants with higher LE8 metrics had more remarkable family income, greater educational achievement, and more stable marital status. Participants with higher LE8 metrics had lower physical activity levels, and they were less prone to being overweight, with a BMI typically&#x02009;&#x0003c;&#x02009;24 kg/m<sup>2</sup>. In comparisons of laboratory indicators, LE8 metrics were negatively correlated with TC, HbA1c, BUN, ALT, and AST, whereas positively correlated with HDL. In addition, the participants with higher LE8 metrics were more inclined to be former or light drinkers or never smokers. They presented lower incidence rates of CVD, DM, hypertension, stroke, and PD. The PA variable, with a missing rate exceeding 10%, was removed in accordance with the established threshold protocol in the subsequent analyses [<xref ref-type="bibr" rid="CR25">25</xref>]. Notably, this removal did not affect the total sample size of 26,975 participants. We also compared the general characteristics of participants with and without PA data (Table S4). The participants without PA data had higher overall LE8 levels and were more likely to fall into the middle and high tertiles of LE8 scores compared to those with PA data.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>General characteristics of the study participants in NHANES 2005&#x02013;2018, weighted</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristics</th><th align="left" colspan="3">LE8 metrics</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left"><bold>Low</bold><break/><bold>(0&#x02009;&#x0003c;&#x02009;LE8&#x02009;&#x02264;&#x02009;60.0)</bold></th><th align="left"><bold>Moderate</bold><break/><bold>(60.0&#x02009;&#x0003c;&#x02009;LE8&#x02009;&#x02264;&#x02009;73.0)</bold></th><th align="left"><bold>High</bold><break/><bold>(73.0&#x02009;&#x0003c;&#x02009;LE8&#x02009;&#x02264;&#x02009;100.0)</bold></th></tr></thead><tbody><tr><td align="left"><bold>N</bold></td><td align="left"><bold>8,989</bold></td><td align="left"><bold>8,667</bold></td><td align="left"><bold>9,319</bold></td><td char="." align="char"/></tr><tr><td align="left"><bold>Age</bold>, years</td><td align="left">52.87&#x02009;&#x000b1;&#x02009;0.24</td><td align="left">49.00&#x02009;&#x000b1;&#x02009;0.30</td><td align="left">43.65&#x02009;&#x000b1;&#x02009;0.34</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>Gender</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Female</td><td align="left">50.41&#x02009;&#x000b1;&#x02009;0.76</td><td align="left">48.09&#x02009;&#x000b1;&#x02009;0.61</td><td align="left">55.83&#x02009;&#x000b1;&#x02009;0.65</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Male</td><td align="left">49.59&#x02009;&#x000b1;&#x02009;0.76</td><td align="left">51.91&#x02009;&#x000b1;&#x02009;0.61</td><td align="left">44.17&#x02009;&#x000b1;&#x02009;0.65</td><td char="." align="char"/></tr><tr><td align="left"><bold>Ethnicity</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Mexican American</td><td align="left">7.52&#x02009;&#x000b1;&#x02009;0.73</td><td align="left">8.60&#x02009;&#x000b1;&#x02009;0.71</td><td align="left">7.45&#x02009;&#x000b1;&#x02009;0.60</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Non-Hispanic Black</td><td align="left">13.83&#x02009;&#x000b1;&#x02009;0.92</td><td align="left">10.75&#x02009;&#x000b1;&#x02009;0.71</td><td align="left">7.06&#x02009;&#x000b1;&#x02009;0.51</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Non-Hispanic White</td><td align="left">68.57&#x02009;&#x000b1;&#x02009;1.48</td><td align="left">69.59&#x02009;&#x000b1;&#x02009;1.35</td><td align="left">71.45&#x02009;&#x000b1;&#x02009;1.23</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Other Race</td><td align="left">10.08&#x02009;&#x000b1;&#x02009;0.60</td><td align="left">11.06&#x02009;&#x000b1;&#x02009;0.60</td><td align="left">14.05&#x02009;&#x000b1;&#x02009;0.75</td><td char="." align="char"/></tr><tr><td align="left"><bold>Education level</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x0003c;&#x02009;High School</td><td align="left">6.82&#x02009;&#x000b1;&#x02009;0.45</td><td align="left">4.66&#x02009;&#x000b1;&#x02009;0.28</td><td align="left">2.94&#x02009;&#x000b1;&#x02009;0.23</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;High School</td><td align="left">45.39&#x02009;&#x000b1;&#x02009;0.93</td><td align="left">35.53&#x02009;&#x000b1;&#x02009;0.85</td><td align="left">21.79&#x02009;&#x000b1;&#x02009;0.85</td><td char="." align="char"/></tr><tr><td align="left">&#x02009;&#x0003e;&#x02009;High School</td><td align="left">47.79&#x02009;&#x000b1;&#x02009;1.02</td><td align="left">59.82&#x02009;&#x000b1;&#x02009;0.92</td><td align="left">75.26&#x02009;&#x000b1;&#x02009;0.94</td><td char="." align="char"/></tr><tr><td align="left"><bold>PIR</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"> &#x0003c;&#x02009;1.3</td><td align="left">26.13&#x02009;&#x000b1;&#x02009;0.97</td><td align="left">19.70&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">14.34&#x02009;&#x000b1;&#x02009;0.60</td><td char="." align="char"/></tr><tr><td align="left">1.3&#x02009;&#x02264;&#x02009;PIR&#x02009;&#x0003c;&#x02009;3.5</td><td align="left">40.89&#x02009;&#x000b1;&#x02009;0.90</td><td align="left">36.54&#x02009;&#x000b1;&#x02009;0.92</td><td align="left">31.77&#x02009;&#x000b1;&#x02009;0.94</td><td char="." align="char"/></tr><tr><td align="left"> &#x02265;&#x02009;3.5</td><td align="left">32.99&#x02009;&#x000b1;&#x02009;1.12</td><td align="left">43.76&#x02009;&#x000b1;&#x02009;1.09</td><td align="left">53.89&#x02009;&#x000b1;&#x02009;1.19</td><td char="." align="char"/></tr><tr><td align="left"><bold>Marital status</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Unpartnered</td><td align="left">37.97&#x02009;&#x000b1;&#x02009;0.78</td><td align="left">35.29&#x02009;&#x000b1;&#x02009;0.82</td><td align="left">32.86&#x02009;&#x000b1;&#x02009;0.87</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Partnered</td><td align="left">62.03&#x02009;&#x000b1;&#x02009;0.78</td><td align="left">64.71&#x02009;&#x000b1;&#x02009;0.82</td><td align="left">67.14&#x02009;&#x000b1;&#x02009;0.87</td><td char="." align="char"/></tr><tr><td align="left"><bold>BMI</bold>, kg/m<sup>2</sup></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"> &#x0003c;&#x02009;24</td><td align="left">8.45&#x02009;&#x000b1;&#x02009;0.47</td><td align="left">16.65&#x02009;&#x000b1;&#x02009;0.62</td><td align="left">39.40&#x02009;&#x000b1;&#x02009;0.73</td><td char="." align="char"/></tr><tr><td align="left"> &#x02265;&#x02009;24</td><td align="left">91.55&#x02009;&#x000b1;&#x02009;0.47</td><td align="left">83.35&#x02009;&#x000b1;&#x02009;0.62</td><td align="left">60.60&#x02009;&#x000b1;&#x02009;0.73</td><td char="." align="char"/></tr><tr><td align="left"><bold>PA</bold>, MET-h/week</td><td align="left">4603.22&#x02009;&#x000b1;&#x02009;169.94</td><td align="left">4755.93&#x02009;&#x000b1;&#x02009;120.13</td><td align="left">4320.69&#x02009;&#x000b1;&#x02009;97.90</td><td char="." align="char">0.002</td></tr><tr><td align="left"><bold>TC</bold>, mg/dL</td><td align="left">205.32&#x02009;&#x000b1;&#x02009;0.69</td><td align="left">196.45&#x02009;&#x000b1;&#x02009;0.75</td><td align="left">184.16&#x02009;&#x000b1;&#x02009;0.51</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>HDL</bold>, mg/dL</td><td align="left">48.31&#x02009;&#x000b1;&#x02009;0.21</td><td align="left">52.39&#x02009;&#x000b1;&#x02009;0.23</td><td align="left">58.73&#x02009;&#x000b1;&#x02009;0.28</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>HbA1c</bold>, %</td><td align="left">5.99&#x02009;&#x000b1;&#x02009;0.02</td><td align="left">5.54&#x02009;&#x000b1;&#x02009;0.01</td><td align="left">5.29&#x02009;&#x000b1;&#x02009;0.01</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>BUN</bold>, mg/dL</td><td align="left">14.15&#x02009;&#x000b1;&#x02009;0.09</td><td align="left">13.74&#x02009;&#x000b1;&#x02009;0.10</td><td align="left">13.32&#x02009;&#x000b1;&#x02009;0.09</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>ALT</bold>, U/L</td><td align="left">27.46&#x02009;&#x000b1;&#x02009;0.33</td><td align="left">25.90&#x02009;&#x000b1;&#x02009;0.23</td><td align="left">22.64&#x02009;&#x000b1;&#x02009;0.19</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>AST</bold>, U/L</td><td align="left">26.08&#x02009;&#x000b1;&#x02009;0.23</td><td align="left">25.21&#x02009;&#x000b1;&#x02009;0.17</td><td align="left">24.48&#x02009;&#x000b1;&#x02009;0.18</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left"><bold>Alcohol drinking</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;None</td><td align="left">9.45&#x02009;&#x000b1;&#x02009;0.43</td><td align="left">10.02&#x02009;&#x000b1;&#x02009;0.50</td><td align="left">11.38&#x02009;&#x000b1;&#x02009;0.73</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Former</td><td align="left">32.97&#x02009;&#x000b1;&#x02009;0.81</td><td align="left">37.29&#x02009;&#x000b1;&#x02009;0.84</td><td align="left">42.71&#x02009;&#x000b1;&#x02009;0.90</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Light</td><td align="left">15.05&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">17.67&#x02009;&#x000b1;&#x02009;0.65</td><td align="left">20.03&#x02009;&#x000b1;&#x02009;0.54</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Moderate</td><td align="left">21.97&#x02009;&#x000b1;&#x02009;0.60</td><td align="left">21.91&#x02009;&#x000b1;&#x02009;0.81</td><td align="left">17.05&#x02009;&#x000b1;&#x02009;0.55</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Heavy</td><td align="left">20.55&#x02009;&#x000b1;&#x02009;0.71</td><td align="left">13.10&#x02009;&#x000b1;&#x02009;0.52</td><td align="left">8.83&#x02009;&#x000b1;&#x02009;0.40</td><td char="." align="char"/></tr><tr><td align="left"><bold>Smoking status</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;Never</td><td align="left">33.32&#x02009;&#x000b1;&#x02009;0.75</td><td align="left">52.29&#x02009;&#x000b1;&#x02009;0.75</td><td align="left">73.39&#x02009;&#x000b1;&#x02009;0.82</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Former</td><td align="left">29.44&#x02009;&#x000b1;&#x02009;0.67</td><td align="left">27.62&#x02009;&#x000b1;&#x02009;0.70</td><td align="left">21.47&#x02009;&#x000b1;&#x02009;0.67</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Current</td><td align="left">37.24&#x02009;&#x000b1;&#x02009;0.73</td><td align="left">20.09&#x02009;&#x000b1;&#x02009;0.54</td><td align="left">5.14&#x02009;&#x000b1;&#x02009;0.33</td><td char="." align="char"/></tr><tr><td align="left"><bold>CVD</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;No</td><td align="left">83.73&#x02009;&#x000b1;&#x02009;0.54</td><td align="left">91.82&#x02009;&#x000b1;&#x02009;0.35</td><td align="left">96.43&#x02009;&#x000b1;&#x02009;0.25</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Yes</td><td align="left">16.27&#x02009;&#x000b1;&#x02009;0.54</td><td align="left">8.18&#x02009;&#x000b1;&#x02009;0.35</td><td align="left">3.57&#x02009;&#x000b1;&#x02009;0.25</td><td char="." align="char"/></tr><tr><td align="left"><bold>DM</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;No</td><td align="left">76.04&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">90.97&#x02009;&#x000b1;&#x02009;0.39</td><td align="left">97.86&#x02009;&#x000b1;&#x02009;0.19</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Yes</td><td align="left">23.96&#x02009;&#x000b1;&#x02009;0.58</td><td align="left">9.03&#x02009;&#x000b1;&#x02009;0.39</td><td align="left">2.14&#x02009;&#x000b1;&#x02009;0.19</td><td char="." align="char"/></tr><tr><td align="left"><bold>Hypertension</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;No</td><td align="left">38.79&#x02009;&#x000b1;&#x02009;0.68</td><td align="left">59.24&#x02009;&#x000b1;&#x02009;0.68</td><td align="left">81.61&#x02009;&#x000b1;&#x02009;0.58</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Yes</td><td align="left">61.21&#x02009;&#x000b1;&#x02009;0.68</td><td align="left">40.76&#x02009;&#x000b1;&#x02009;0.68</td><td align="left">18.39&#x02009;&#x000b1;&#x02009;0.58</td><td char="." align="char"/></tr><tr><td align="left"><bold>Stroke</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;No</td><td align="left">94.39&#x02009;&#x000b1;&#x02009;0.31</td><td align="left">97.70&#x02009;&#x000b1;&#x02009;0.19</td><td align="left">98.98&#x02009;&#x000b1;&#x02009;0.12</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Yes</td><td align="left">5.61&#x02009;&#x000b1;&#x02009;0.31</td><td align="left">2.30&#x02009;&#x000b1;&#x02009;0.19</td><td align="left">1.02&#x02009;&#x000b1;&#x02009;0.12</td><td char="." align="char"/></tr><tr><td align="left"><bold>PD</bold></td><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02003;No</td><td align="left">98.46&#x02009;&#x000b1;&#x02009;0.17</td><td align="left">99.04&#x02009;&#x000b1;&#x02009;0.14</td><td align="left">99.46&#x02009;&#x000b1;&#x02009;0.10</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Yes</td><td align="left">1.54&#x02009;&#x000b1;&#x02009;0.17</td><td align="left">0.96&#x02009;&#x000b1;&#x02009;0.14</td><td align="left">0.54&#x02009;&#x000b1;&#x02009;0.10</td><td char="." align="char"/></tr></tbody></table><table-wrap-foot><p>The continuous variables were described by weighted mean&#x02009;&#x000b1;&#x02009;standard error (SE), while the categorical variables were described by weighted percentage (%)&#x02009;&#x000b1;&#x02009;SE. The weighted ANOVA analysis was used to assess the differences of the continuous variables, while the weighted chi-square test was used to assess the differences of the categorical variables</p><p><italic>LE8</italic> Life's essential 8, <italic>PIR</italic> Poverty-to-income ratio, <italic>BMI</italic> Body mass index, <italic>PA</italic> Physical activity, <italic>TC</italic> total cholesterol, <italic>HDL</italic> High-density lipoprotein, <italic>HbA1c</italic> glycated hemoglobin, <italic>BUN</italic> Blood urea nitrogen, <italic>ALT</italic> Alanine transaminase, <italic>AST</italic> Aspartate aminotransferase, <italic>CVD</italic> Cardiovascular diseases, <italic>DM</italic> Diabetes mellitus, <italic>PD</italic> Parkinson's disease</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Association between LE8 metrics and PD</title><p id="Par17">To assess the collinearity among variables, we performed the VIF analysis. According to Table <xref rid="Tab2" ref-type="table">2</xref>, the VIF values ranged from 1.083 (for marital status) to 2.778 (for ALT). Although BMI was one of the components of LE8 metrics, its VIF value was 1.542, while LE8 metrics had a VIF value of 2.717, suggesting no significant collinearity between them. Overall, the VIF values of all variables were all&#x02009;&#x0003c;&#x02009;5, indicating that the collinearity of these variables was weak and suitable for the next logistic regression analysis. Table <xref rid="Tab3" ref-type="table">3</xref> presented the association between LE8 metrics and PD. Overall, LE8 metrics were significantly associated with a lower probability of developing PD, as shown across three multivariate logistic regression models, each with an OR of 0.97 (unadjusted model [95% CI: 0.96&#x02013;0.98, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01], partially adjusted model [95% CI: 0.97&#x02013;0.98, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01], fully adjusted model [95% CI: 0.95&#x02013;0.98, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01]). When LE8 metrics were categorized into three groups, we observed a notable decrease in the OR from moderate group (OR: 0.63, 95% CI: 0.48&#x02013;0.83, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) to high group (OR: 0.37, 95% CI: 0.27&#x02013;0.50, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) in Model 1. After partially adjusting for covariates in Model 2, the ORs of PD were 0.74 (95% CI: 0.55&#x02013;0.97, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) in moderate group, and 0.51 (95% CI: 0.36&#x02013;0.72, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) in high group compared with low group. This reverse dose&#x02013;response trend was also observed in Model 3 after adjustment for accessorial covariates, especially in high group (OR: 0.51, 95% CI: 0.32&#x02013;0.81, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01). These results implied that higher LE8 levels were associated with a reduced likelihood of developing PD.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>The results of VIF to assess collinearity between influencing variables for PD</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variables</th><th align="left">VIF</th><th align="left">Variables</th><th align="left">VIF</th></tr></thead><tbody><tr><td align="left">Gender</td><td char="." align="char">1.228</td><td align="left">Age</td><td char="." align="char">1.730</td></tr><tr><td align="left">Ethnicity</td><td char="." align="char">1.095</td><td align="left">Education level</td><td char="." align="char">1.293</td></tr><tr><td align="left">PIR</td><td char="." align="char">1.329</td><td align="left">Marital status</td><td char="." align="char">1.083</td></tr><tr><td align="left">BMI</td><td char="." align="char">1.542</td><td align="left">Smoking status</td><td char="." align="char">1.503</td></tr><tr><td align="left">Stroke</td><td char="." align="char">1.466</td><td align="left">Alcohol drinking</td><td char="." align="char">1.090</td></tr><tr><td align="left">CVD</td><td char="." align="char">1.675</td><td align="left">HbA1c</td><td char="." align="char">1.911</td></tr><tr><td align="left">DM</td><td char="." align="char">1.959</td><td align="left">ALT</td><td char="." align="char">2.778</td></tr><tr><td align="left">Hypertension</td><td char="." align="char">1.504</td><td align="left">AST</td><td char="." align="char">2.646</td></tr><tr><td align="left">BUN</td><td char="." align="char">1.270</td><td align="left">TC</td><td char="." align="char">1.279</td></tr><tr><td align="left">HDL</td><td char="." align="char">1.378</td><td align="left">LE8</td><td char="." align="char">2.717</td></tr></tbody></table><table-wrap-foot><p><italic>PIR</italic> Poverty-to-income ratio, <italic>BMI</italic> Body mass index, <italic>TC</italic> Total cholesterol, <italic>HDL</italic> High-density lipoprotein, <italic>HbA1c</italic> Glycated hemoglobin, <italic>BUN</italic> Blood urea nitrogen, <italic>ALT</italic> Alanine transaminase, <italic>AST</italic> Aspartate aminotransferase, <italic>CVD</italic> Cardiovascular diseases, <italic>LE8</italic> Life's essential 8, <italic>DM</italic> Diabetes mellitus</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Multivariate logistic regression models</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2"><bold>Model 1</bold><sup><bold>a</bold></sup></th><th align="left" colspan="2"><bold>Model 2</bold><sup><bold>b</bold></sup></th><th align="left" colspan="2"><bold>Model 3</bold><sup><bold>c</bold></sup></th></tr><tr><th align="left"><bold>OR </bold><bold>(95%CI)</bold></th><th align="left"><bold><italic>P</italic></bold></th><th align="left"><bold>OR </bold><bold>(95%CI)</bold></th><th align="left"><bold><italic>P</italic></bold></th><th align="left"><bold>OR </bold><bold>(95%CI)</bold></th><th align="left"><bold><italic>P</italic></bold></th></tr></thead><tbody><tr><td align="left">LE8</td><td align="left">0.97 (0.96&#x02013;0.98)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.97 (0.97&#x02013;0.98)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.97 (0.95&#x02013;0.98)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" colspan="7"><bold>LE8 tertile</bold></td></tr><tr><td align="left">&#x02003;Low</td><td align="left">Reference</td><td char="." align="char"/><td align="left">Reference</td><td char="." align="char"/><td align="left">Reference</td><td char="." align="char"/></tr><tr><td align="left">&#x02003;Moderate</td><td align="left">0.63 (0.48&#x02013;0.83)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.74 (0.55&#x02013;0.97)</td><td char="." align="char">0.040</td><td align="left">0.79 (0.57&#x02013;1.10)</td><td char="." align="char">0.159</td></tr><tr><td align="left">&#x02003;High</td><td align="left">0.37 (0.27&#x02013;0.50)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.51 (0.36&#x02013;0.72)</td><td char="." align="char">&#x02009;&#x0003c;&#x02009;0.001</td><td align="left">0.51 (0.32&#x02013;0.81)</td><td char="." align="char">0.004</td></tr></tbody></table><table-wrap-foot><p><italic>LE8</italic> Life's essential 8, <italic>OR</italic> Odds ratio, <italic>95%CI</italic> 95% confidence interval</p><p><sup>a</sup>Unadjusted</p><p><sup>b</sup>(Partially adjusted model): Adjusted for age, gender, ethnicity, education level, marital status, PIR</p><p><sup>c</sup>(Fully adjusted model): b&#x02009;+&#x02009;adjusted for BMI, ALT, AST, HbA1c, BUN, HDL, TC, smoking status, alcohol drinking, CVD, DM, stroke, and hypertension</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Sensitivity analysis</title><p id="Par18">To evaluate the potential impact of MIs strategies on handling missing values, we generated 10 imputed datasets and 1 combined dataset for sensitivity analysis, which included PA variable. As shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>A, the ORs across all datasets remained consistently close to 0.97, verifying a significant association between higher LE8 levels and a reduced risk of PD. To assess whether the PA removal might introduce underlying bias, we reanalyzed the dataset without PA variable. As illustrated in Fig. <xref rid="Fig3" ref-type="fig">3</xref>B, the pooled results across all datasets also remained consistently close to 0.97, matching the ORs obtained from the MIs analysis with PA variable. These findings affirmed that, the MIs strategy and the removal of PA variable were aligned with established best practices and ensured the robustness and reliability of the observed LE8-PD association.<fig id="Fig3"><label>Fig. 3</label><caption><p>Forest plots from multiple imputations. Forest plot from multiple imputations with PA variable (10 times) (<bold>A</bold>). Forest plot from multiple imputations without PA variable (10 times) (<bold>B</bold>). OR, odds ratio; 95%CI, 95% confidence interval</p></caption><graphic xlink:href="12889_2025_21648_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec12"><title>Restricted cubic spline analysis</title><p id="Par19">To evaluate the nonlinear association of LE8 metrics and PD, we conducted RCS plots with 4 knots. As shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>A, the continuous LE8 true score demonstrated a dose&#x02013;response relationship with PD probability, where higher LE8 scores were associated with a decreased probability of PD (<italic>P</italic>
<sub>nonlinearity</sub>&#x02009;&#x0003c;&#x02009;0.01). To further examine this nonlinear effect, we categorized LE8 metrics into tertiles. A significant finding from Fig. <xref rid="Fig4" ref-type="fig">4</xref>B was that the participants in higher tertiles (higher LE8 scores) tended to had a lower adjusted probability of PD (<italic>P</italic>
<sub>nonlinearity</sub>&#x02009;&#x0003c;&#x02009;0.01).<fig id="Fig4"><label>Fig. 4</label><caption><p>Restricted cubic spline plots with 4 knots. Restricted cubic spline plot illustrating the non-linear association between continuous LE8 true score and the probability of Parkinson's disease. The red line represented the odds ratios, while the blue line denoted the 95% confidence intervals (<bold>A</bold>). Restricted cubic spline plot illustrating the adjusted probability of Parkinson's disease according to LE8 tertiles. Error bars represented 95% confidence intervals (<bold>B</bold>). LE8, Life's essential 8. PD, Parkinson's disease</p></caption><graphic xlink:href="12889_2025_21648_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec13"><title>Subgroup analysis and interaction test</title><p id="Par20">To investigate the stability of the reverse association between LE8 metrics and PD, we further carried out the subgroup analysis. We found that the interaction was not remarkable after stratification by ethnicity, education level, PIR, marital status, BMI, TC, HDL, HbA1c, BUN, ALT, AST, smoking status, DM, CVD, and hypertension (All <italic>P</italic>
<sub>interaction</sub>&#x02009;&#x0003e;&#x02009;0.05), revealing that the connection remained stable without affecting by these covariates (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Although the <italic>P</italic> for interaction for subgroups such as alcohol drinking, age, and stroke were all&#x02009;&#x0003c;&#x02009;0.05, the corresponding 95% CIs of the OR values crossed 1, indicating that these variables did not demonstrate a true interaction with LE8 metrics. In contrast, only the gender subgroup showed a significant interaction, highlighted in red (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). Specifically, an OR of 0.96 suggested that, in female participants, higher levels of LE8 were associated with a 4% reduction in the probability of developing PD compared to lower levels (<italic>P</italic>
<sub>interaction</sub>&#x02009;=&#x02009;0.029). Detailed information was provided in Table S5. This finding suggested that the effect of LE8 on PD was significantly influenced by gender. To further explore the observed gender-specific interactions, we analyzed the general characteristics of female and male participants separately. These analyses provided additional insights into observed gender interactions and their role in modifying the relationship between LE8 metrics and PD. More details were listed in Table S6 and Table S7.<fig id="Fig5"><label>Fig. 5</label><caption><p>Forest plot subgroup analysis and interaction test between LE8 metrics and PD (<italic>P</italic> for interaction&#x02009;&#x0003e;&#x02009;0.05). PIR, poverty-to-income ratio; BMI, body mass index; TC, total cholesterol; HDL, high-density lipoprotein; HbA1c, glycated hemoglobin; BUN, blood urea nitrogen; ALT, alanine transaminase; AST, aspartate aminotransferase; CVD, cardiovascular diseases; DM, diabetes mellitus; OR, odds ratio; 95%CI, 95% confidence interval</p></caption><graphic xlink:href="12889_2025_21648_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Forest plot subgroup analysis and interaction test between LE8 metrics and PD (<italic>P</italic> for interaction&#x02009;&#x0003c;&#x02009;0.05). The gender subgroup showed a significant interaction on LE8-PD association, highlighted in red. OR, odds ratio; 95%CI, 95% confidence interval</p></caption><graphic xlink:href="12889_2025_21648_Fig6_HTML" id="MO6"/></fig></p></sec></sec><sec id="Sec14"><title>Discussion</title><p id="Par21">This was the first cross-sectional survey of the association between the CVH status of the US adults via the AHA's updated LE8 metrics and PD. A notably reverse association between LE8 metrics and PD was observed via multivariate logistic regression models, which was consistent with the results of the sensitivity analysis and RCS analysis. Subgroup analysis revealed that gender exerted an effect in modifying this connection, with female exhibiting a stronger connection.</p><p id="Par22">Previous evidence had established that multiple risk factors (such as high fat intake, and DM) contribute to PD etiology and progression [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Furthermore, intensive interventions targeting alterable biochemical indices and lifestyles had been confirmed to lead to favorable benefits PD patients [<xref ref-type="bibr" rid="CR28">28</xref>]. As an improved scoring algorithm that incorporated the sleep health in LS7, the LE8 metrics was validated their practicability and universality in clinical scenarios [<xref ref-type="bibr" rid="CR8">8</xref>]. A prospective analysis revealed that adhering to a favorable lifestyle and attaining a high LE8 score could prevent 66.8% and 77.3% of severe new-onset nonalcoholic fatty liver disease, which was independent of genetic risks [<xref ref-type="bibr" rid="CR29">29</xref>]. Unfortunately, the linkage between improved LE8 metrics and PD had never been explored before. Our investigation addressed the knowledge gap in this field, and the logistic regression model suggested that a higher LE8 metrics was significantly associated with a lower risk of developing PD in a dose&#x02013;response manner. This reverse effect kept consistent with the results of sensitivity analysis and RCS analysis, implying that favorable LE8 metrics might exerted a beneficial role in reducing PD. These findings, along with previous evidence [<xref ref-type="bibr" rid="CR30">30</xref>], strongly support that the clinicians should shine a spotlight on therapeutic strategies that improve LE8 metrics and reinforce success in pursuing a healthier CVH.</p><p id="Par23">The underlying mechanism linking LE8 metrics and PD remained elusive in the existing literature. Therefore, we could only speculate the potential mechanism based on the current knowledge. Since LE8 metrics integrate by biological and behavioral components, this improved approach underscored that the plausible biological effects might underpin the connection of PD with abnormal metabolic conditions and unhealthy lifestyles, involving crosstalks of some pathways, including inflammation, insulin resistance, oxidative stress, as well as lipid metabolism [<xref ref-type="bibr" rid="CR6">6</xref>]. For example, inflammation, as a strong trigger of CVD, was conducive to the aggregation of &#x003b1;-Syn and diffusion in the brain, further exacerbating inflammatory responses during PD progression [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Besides, a high-fat diet, a pivotal contributor to metabolic disorders in CVD, could increase the vulnerability of the body to neurotoxin injury and dopamine depletion in the substantia nigra, which degenerated the development of PD [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. This study revealed that participants with higher LE8 scores were more likely to have a BMI&#x02009;&#x0003c;&#x02009;24 kg/m<sup>2</sup>, suggesting that avoiding obesity might be linked to improved CVH. Urgent studies should be conducted to elucidate the precise underpinning mechanism.</p><p id="Par24">This study observed that Non-Hispanic White were the most represented ethnicity, and were positively correlated with LE8 metrics, whereas Non-Hispanic Black were negatively correlated with LE8 metrics. A cautiously conjected factor might be differences in available social resources, health care, combined with the incidence of PD and high LE8 metrics among different ethnic subgroups [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Consistent with prior evidence [<xref ref-type="bibr" rid="CR39">39</xref>], we also concluded the participants with healthier CVH received higher education and held more income than did those with low CVH levels, indirectly supporting our speculation. On the basis of the finding shown here, the sensitivity of LE8 metrics should also be enhanced at the population level in response to policy changes, ethnicity disparities, or other influences. More precise strategies for maintaining a high CVH status would hold great promise for dramatic shrinkage in the future burden PD and improved health equity.</p><p id="Par25">Another interesting finding of this study was that the association between LE8 metrics and PD appeared to be influenced by gender, with female showing a stronger effect compared to male. Gender disparities in PD have been well-documented, with male having twice the probability of developing PD compared to female, as well as differing clinical symptoms and responses to treatment [<xref ref-type="bibr" rid="CR40">40</xref>]. One possible explanation for our findings was that LE8 metrics themselves might be gender-related, as baseline characteristics indicated that participants with higher LE8 scores were more likely to be female. Additionally, previous studies, such as Fanny et al. [<xref ref-type="bibr" rid="CR30">30</xref>], reported that higher LE8 metrics had a stronger beneficial effect on reducing the risk of all-cause dementia in female compared to male. Although the joint effect of gender and LE8 metrics on PD remains unclear, these findings highlight the need to investigate potential gender-related mechanism in the LE8-PD relationship. Such mechanism may involve hormonal, genetic, lifestyle, and environmental interactions. Identifying these differences is critical for tailoring interventions to specific populations of PD patients who could benefit most from improving LE8 metrics. In contrast, in other subgroups, such as alcohol drinking and stroke history, the 95% CIs crossed 1, indicating no significant interaction between LE8 metrics and these factors in relation to PD. These results suggested that the effects of LE8 metrics may vary across different subgroups, further emphasizing the importance of investigating population-specific characteristics that could modify the LE8-PD relationship. Future research should prioritize understanding these gender-specific and subgroup-related factors to inform personalized prevention and management strategies for PD and effectively address health disparities.</p><p id="Par26">A graphical summary illustrated the key findings of this study (Fig. <xref rid="Fig7" ref-type="fig">7</xref>), showing that pursuing a higher CVH level is associated with a lower probability of developing PD, which has significant implications for clinical practice. LE8 is anticipated to serve as a valuable tool for PD risk assessment, with ongoing efforts to develop a LE8-based nomogram model and explore its integration with environmental factors [<xref ref-type="bibr" rid="CR41">41</xref>] for improved precision. Since many LE8 components, such as diet, sleep, and physical activity, are modifiable, targeted interventions to address gender-based CVH disparities could potentially help lower the probability of developing PD. Public health initiatives promoting LE8 as a preventive metric could encourage healthier behaviors on a population level, while personalized medicine approaches may use LE8 metrics to tailor lifestyle recommendations for individuals. As highlighted by Nguyen XT et al. [<xref ref-type="bibr" rid="CR42">42</xref>], the adoption and promotion of lifestyle modifications, with or without direct support from healthcare practitioners, can empower individuals to independently reduce disease burden. If further validated, LE8 holds potential to be integrated into clinical guidelines for PD prevention and management, providing a framework for risk stratification, lifestyle interventions, and public health strategies to reduce the burden of PD. Future studies, particularly large-scale cohort studies or randomized controlled trials, could build upon this study to identify which items form LE8 metrics are most strongly associated with PD and which are less significant. These studies could further validate our findings and provide longitudinal insights. Additionally, exploring the association or causality between LE8 metrics and PD prodromal symptoms [<xref ref-type="bibr" rid="CR43">43</xref>] will be an exciting and promising research direction.<fig id="Fig7"><label>Fig. 7</label><caption><p>The graphic summary in this study. LE8, Life's essential 8; PD, Parkinson's disease; CVH, cardiovascular health; BMI, body mass index</p></caption><graphic xlink:href="12889_2025_21648_Fig7_HTML" id="MO7"/></fig></p><p id="Par27">There were several limitations should be acknowledged. Firstly, the data were based on 7 cycles over a relatively short time period (&#x0003c;&#x02009;15 years), caution should be exercised when generalizing the findings to secular trends between LE8 metrics and PD as restricted to timeliness. Secondly, we ruled out a comprehensive list of confounding covariates in the analyzes, but those unmeasured or residual confounders should not be neglected. Although we discussed the mechanism underlying the indicated associations between CVH and PD, the specific mechanism of this effect needs to be further explored at the molecular or cellular level. And PD identification in this study was based on the use of specific medications commonly prescribed for its treatment. While this approach carried an inherent risk of bias that might impact result validity, it is worth noting that even clinical PD diagnoses remained speculative, as a definitive diagnosis could only be confirmed through post-mortem examination [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Notably, the cross-sectional nature of the NHANES study inherently limited the ability to establish causal inferences between LE8 metrics and PD, as it prevented the determination of temporal relationships or directionality. To establish robust causality, future research should prioritize preclinical and clinical randomized controlled trials with large sample sizes, involving not only US citizens but also populations from other countries.</p></sec><sec id="Sec15"><title>Conclusions</title><p id="Par28">Taken together, this study hinted at a reverse association between LE8 metrics and PD in a dose&#x02013;response pattern using NHANES 2005&#x02013;2018 data, more pronounced in female compared to male. These findings highlight the potential of the LE8 metrics to guide targeted strategies for addressing gender-based CVH disparities, offering beneficial insights for the tertiary prevention of PD, reduction of health expenditure, and extension of healthy longevity, with the promise of greater social well-being and health equity. The key for future investigations is to clarify their robust causal linkage in large-scale and multiregional randomized controlled trials and further explore the underpinning mechanism of this association.</p></sec><sec id="Sec190" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12889_2025_21648_MOESM1_ESM.docx"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12889_2025_21648_MOESM2_ESM.pdf"><caption><p>Supplementary Material 2.</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Jiaxin Fan and Yanfeng Wang contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We sincerely thank National Center for Health Statistics Institutional staff for their elaborate design, data collection, NHANES database maintenance, and sharing precious NHANES resources.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>FJX, WYF, ZSQ, and LR contributed to the design and conceptualization of this study; FJX and WYF conducted the study, curated, analyzed the data, and drafted the manuscript; FJX populated all tables and figures; GXZ assisted with all data management; CS provided software and code information; ZSQ and LR critically revised the draft and provided detail commentary; LR supervised all aspects of the work.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by Natural Science Basic Research Project in Shaanxi Province (2024JC-YBQN-0861), Key Innovation Cluster in Social Health Development Project in Shaanxi Province (2022ZDLSF04-06), and Huatong Guokang Medical Research Special Project (2023HT056).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All NHANES data supporting the findings of this study can be found here <ext-link ext-link-type="uri" xlink:href="https://wwwn.cdc.gov/nchs/nhanes/default.aspx">https://wwwn.cdc.gov/nchs/nhanes/default.aspx</ext-link>, which are available for public use. And they are also obtainable from the corresponding author, upon reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par29">The NCHS Ethics Review Board reviewed and approved NHANES survey <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/nchs/nhanes/irba98.htm">https://www.cdc.gov/nchs/nhanes/irba98.htm</ext-link>, and the informed consents of all participants were signed. Considering the attributes of open access and deidentification, this study was exempted from the ethical approval of the Shaanxi Provincial People's Hospital Ethics Committee.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par30">All authors have read, validate the accuracy of the data and approved the final manuscript.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par31">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Bloem</surname><given-names>BR</given-names></name><name><surname>Okun</surname><given-names>MS</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name></person-group><article-title>Parkinson's disease</article-title><source>Lancet</source><year>2021</year><volume>397</volume><issue>10291</issue><fpage>2284</fpage><lpage>2303</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)00218-X</pub-id><pub-id pub-id-type="pmid">33848468</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Bloem BR, Okun MS, Klein C. Parkinson&#x02019;s disease. Lancet. 2021;397(10291):2284&#x02013;303.<pub-id pub-id-type="pmid">33848468</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Tolosa</surname><given-names>E</given-names></name><name><surname>Garrido</surname><given-names>A</given-names></name><name><surname>Scholz</surname><given-names>SW</given-names></name><name><surname>Poewe</surname><given-names>W</given-names></name></person-group><article-title>Challenges in the diagnosis of Parkinson's disease</article-title><source>Lancet Neurol</source><year>2021</year><volume>20</volume><issue>5</issue><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(21)00030-2</pub-id><pub-id pub-id-type="pmid">33894193</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson&#x02019;s disease. Lancet Neurol. 2021;20(5):385&#x02013;97.<pub-id pub-id-type="pmid">33894193</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname><given-names>ER</given-names></name><name><surname>Constantinescu</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030</article-title><source>Neurology</source><year>2007</year><volume>68</volume><issue>5</issue><fpage>384</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000247740.47667.03</pub-id><pub-id pub-id-type="pmid">17082464</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384&#x02013;6.<pub-id pub-id-type="pmid">17082464</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><collab>GBD 2016 Neurology Collaborators</collab></person-group><article-title>Global, regional, and national burden of neurological disorders, 1990&#x02013;2016: a systematic analysis for the global burden of disease study 2016</article-title><source>Lancet Neurol</source><year>2019</year><volume>18</volume><issue>5</issue><fpage>459</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(18)30499-X</pub-id><pub-id pub-id-type="pmid">30879893</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990&#x02013;2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459&#x02013;80.<pub-id pub-id-type="pmid">30879893</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>DK</given-names></name><name><surname>Tanner</surname><given-names>CM</given-names></name><name><surname>Brundin</surname><given-names>P</given-names></name></person-group><article-title>Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology</article-title><source>Clin Geriatr Med</source><year>2020</year><volume>36</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.cger.2019.08.002</pub-id><pub-id pub-id-type="pmid">31733690</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Simon DK, Tanner CM, Brundin P. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clin Geriatr Med. 2020;36(1):1&#x02013;12.<pub-id pub-id-type="pmid">31733690</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Potashkin</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><etal/></person-group><article-title>Understanding the links between cardiovascular disease and Parkinson's disease</article-title><source>Mov Disord</source><year>2020</year><volume>35</volume><issue>1</issue><fpage>55</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1002/mds.27836</pub-id><pub-id pub-id-type="pmid">31483535</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Potashkin J, Huang X, Becker C, et al. Understanding the links between cardiovascular disease and Parkinson&#x02019;s disease. Mov Disord. 2020;35(1):55&#x02013;74.<pub-id pub-id-type="pmid">31483535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Jones</surname><given-names>DM</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Labarthe</surname><given-names>D</given-names></name><etal/></person-group><article-title>Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond</article-title><source>Circulation</source><year>2010</year><volume>121</volume><issue>4</issue><fpage>586</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.192703</pub-id><pub-id pub-id-type="pmid">20089546</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association&#x02019;s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586&#x02013;613.<pub-id pub-id-type="pmid">20089546</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Jones</surname><given-names>DM</given-names></name><name><surname>Allen</surname><given-names>NB</given-names></name><name><surname>Anderson</surname><given-names>CAM</given-names></name><etal/></person-group><article-title>Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association</article-title><source>Circulation</source><year>2022</year><volume>146</volume><issue>5</issue><fpage>e18</fpage><lpage>e43</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000001078</pub-id><pub-id pub-id-type="pmid">35766027</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life&#x02019;s Essential 8: Updating and Enhancing the American Heart Association&#x02019;s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation. 2022;146(5):e18&#x02013;43.<pub-id pub-id-type="pmid">35766027</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>SE</given-names></name><name><surname>Shroff</surname><given-names>GR</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients</article-title><source>J Am Heart Assoc</source><year>2012</year><volume>1</volume><issue>4</issue><fpage>e002097</fpage><pub-id pub-id-type="doi">10.1161/JAHA.112.002097</pub-id><pub-id pub-id-type="pmid">23130165</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Nelson SE, Shroff GR, Li S, et al. Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients. J Am Heart Assoc. 2012;1(4):e002097.<pub-id pub-id-type="pmid">23130165</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>L</given-names></name><name><surname>Troxel</surname><given-names>W</given-names></name><name><surname>Buysse</surname><given-names>DJ</given-names></name></person-group><article-title>Sleep Health: An Opportunity for Public Health to Address Health Equity</article-title><source>Annu Rev Public Health</source><year>2020</year><volume>41</volume><fpage>81</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1146/annurev-publhealth-040119-094412</pub-id><pub-id pub-id-type="pmid">31900098</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Hale L, Troxel W, Buysse DJ. Sleep Health: An Opportunity for Public Health to Address Health Equity. Annu Rev Public Health. 2020;41:81&#x02013;99.<pub-id pub-id-type="pmid">31900098</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Virani</surname><given-names>SS</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Aparicio</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association</article-title><source>Circulation</source><year>2021</year><volume>143</volume><issue>8</issue><fpage>e254</fpage><lpage>e743</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000950</pub-id><pub-id pub-id-type="pmid">33501848</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254&#x02013;743.<pub-id pub-id-type="pmid">33501848</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen-Torvik</surname><given-names>LJ</given-names></name><name><surname>Shay</surname><given-names>CM</given-names></name><name><surname>Abramson</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study</article-title><source>Circulation</source><year>2013</year><volume>127</volume><issue>12</issue><fpage>1270</fpage><lpage>1275</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.001183</pub-id><pub-id pub-id-type="pmid">23509058</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Rasmussen-Torvik LJ, Shay CM, Abramson JG, et al. Ideal cardiovascular health is inversely associated with incident cancer: the Atherosclerosis Risk In Communities study. Circulation. 2013;127(12):1270&#x02013;5.<pub-id pub-id-type="pmid">23509058</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Ahluwalia</surname><given-names>N</given-names></name><name><surname>Dwyer</surname><given-names>J</given-names></name><name><surname>Terry</surname><given-names>A</given-names></name><etal/></person-group><article-title>Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy</article-title><source>Adv Nutr</source><year>2016</year><volume>7</volume><issue>1</issue><fpage>121</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.3945/an.115.009258</pub-id><pub-id pub-id-type="pmid">26773020</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Ahluwalia N, Dwyer J, Terry A, et al. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv Nutr. 2016;7(1):121&#x02013;34.<pub-id pub-id-type="pmid">26773020</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Paulose-Ram</surname><given-names>R</given-names></name><name><surname>Graber</surname><given-names>JE</given-names></name><name><surname>Woodwell</surname><given-names>D</given-names></name><etal/></person-group><article-title>The National Health and Nutrition Examination Survey (NHANES), 2021&#x02013;2022: Adapting Data Collection in a COVID-19 Environment</article-title><source>Am J Public Health</source><year>2021</year><volume>111</volume><issue>12</issue><fpage>2149</fpage><lpage>2156</lpage><pub-id pub-id-type="doi">10.2105/AJPH.2021.306517</pub-id><pub-id pub-id-type="pmid">34878854</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Paulose-Ram R, Graber JE, Woodwell D, et al. The National Health and Nutrition Examination Survey (NHANES), 2021&#x02013;2022: Adapting Data Collection in a COVID-19 Environment. Am J Public Health. 2021;111(12):2149&#x02013;56.<pub-id pub-id-type="pmid">34878854</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><etal/></person-group><article-title>Using the New "Life's Essential 8" Metrics to Evaluate Trends in Cardiovascular Health Among US Adults From 2005 to 2018: Analysis of Serial Cross-sectional Studies</article-title><source>JMIR Public Health Surveill</source><year>2023</year><volume>9</volume><fpage>e45521</fpage><pub-id pub-id-type="doi">10.2196/45521</pub-id><pub-id pub-id-type="pmid">37155232</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Li C, Li Y, Zhao M, et al. Using the New &#x0201c;Life&#x02019;s Essential 8&#x0201d; Metrics to Evaluate Trends in Cardiovascular Health Among US Adults From 2005 to 2018: Analysis of Serial Cross-sectional Studies. JMIR Public Health Surveill. 2023;9:e45521.<pub-id pub-id-type="pmid">37155232</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Cen</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name></person-group><article-title>Association between blood selenium with parkinson's disease in the US (NHANES 2011&#x02013;2020)</article-title><source>Environ Sci Pollut Res Int</source><year>2023</year><volume>30</volume><issue>55</issue><fpage>117349</fpage><lpage>117359</lpage><pub-id pub-id-type="doi">10.1007/s11356-023-30337-7</pub-id><pub-id pub-id-type="pmid">37864700</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Zeng Z, Cen Y, Luo X. Association between blood selenium with parkinson&#x02019;s disease in the US (NHANES 2011&#x02013;2020). Environ Sci Pollut Res Int. 2023;30(55):117349&#x02013;59.<pub-id pub-id-type="pmid">37864700</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Botelho</surname><given-names>J</given-names></name><name><surname>Lyra</surname><given-names>P</given-names></name><name><surname>Proen&#x000e7;a</surname><given-names>L</given-names></name><etal/></person-group><article-title>Relationship between Blood and Standard Biochemistry Levels with Periodontitis in Parkinson's Disease Patients: Data from the NHANES 2011&#x02013;2012</article-title><source>J Pers Med</source><year>2020</year><volume>10</volume><issue>3</issue><fpage>69</fpage><pub-id pub-id-type="doi">10.3390/jpm10030069</pub-id><pub-id pub-id-type="pmid">32722393</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Botelho J, Lyra P, Proen&#x000e7;a L, et al. Relationship between Blood and Standard Biochemistry Levels with Periodontitis in Parkinson&#x02019;s Disease Patients: Data from the NHANES 2011&#x02013;2012. J Pers Med. 2020;10(3):69.<pub-id pub-id-type="pmid">32722393</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Zhang Y, Ning N, Fan X, Huang R, Ye Y, He Y, et al. Age-dependent interaction between Life's Essential 8 and chronic kidney disease: A national cross-sectional analysis. Prev Med. 2023;177:107763. 10.1016/j.ypmed.2023.107763.</mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Association between life's essential 8 and biological ageing among US adults</article-title><source>J Transl Med</source><year>2023</year><volume>21</volume><issue>1</issue><fpage>622</fpage><pub-id pub-id-type="doi">10.1186/s12967-023-04495-8</pub-id><pub-id pub-id-type="pmid">37710295</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Zhang R, Wu M, Zhang W, et al. Association between life&#x02019;s essential 8 and biological ageing among US adults. J Transl Med. 2023;21(1):622.<pub-id pub-id-type="pmid">37710295</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs-Smith</surname><given-names>SM</given-names></name><name><surname>Pannucci</surname><given-names>TE</given-names></name><name><surname>Subar</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Update of the Healthy Eating Index: HEI-2015</article-title><source>J Acad Nutr Diet</source><year>2018</year><volume>118</volume><issue>9</issue><fpage>1591</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1016/j.jand.2018.05.021</pub-id><pub-id pub-id-type="pmid">30146071</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Krebs-Smith SM, Pannucci TE, Subar AF, et al. Update of the Healthy Eating Index: HEI-2015. J Acad Nutr Diet. 2018;118(9):1591&#x02013;602.<pub-id pub-id-type="pmid">30146071</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Zipf</surname><given-names>G</given-names></name><name><surname>Chiappa</surname><given-names>M</given-names></name><name><surname>Porter</surname><given-names>KS</given-names></name><etal/></person-group><article-title>National health and nutrition examination survey: plan and operations, 1999&#x02013;2010</article-title><source>Vital Health Stat 1</source><year>2013</year><volume>56</volume><fpage>1</fpage><lpage>37</lpage></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zipf G, Chiappa M, Porter KS, et al. National health and nutrition examination survey: plan and operations, 1999&#x02013;2010. Vital Health Stat 1. 2013;56:1&#x02013;37.</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Malin</surname><given-names>AJ</given-names></name><name><surname>Lesseur</surname><given-names>C</given-names></name><name><surname>Busgang</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Fluoride exposure and kidney and liver function among adolescents in the United States: NHANES, 2013&#x02013;2016</article-title><source>Environ Int</source><year>2019</year><volume>132</volume><fpage>105012</fpage><pub-id pub-id-type="doi">10.1016/j.envint.2019.105012</pub-id><pub-id pub-id-type="pmid">31402058</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Malin AJ, Lesseur C, Busgang SA, et al. Fluoride exposure and kidney and liver function among adolescents in the United States: NHANES, 2013&#x02013;2016. Environ Int. 2019;132:105012.<pub-id pub-id-type="pmid">31402058</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Issanov</surname><given-names>A</given-names></name><name><surname>Karim</surname><given-names>ME</given-names></name><name><surname>Aimagambetova</surname><given-names>G</given-names></name><etal/></person-group><article-title>Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011&#x02013;2018)</article-title><source>Vaccines (Basel)</source><year>2022</year><volume>10</volume><issue>12</issue><fpage>2113</fpage><pub-id pub-id-type="doi">10.3390/vaccines10122113</pub-id><pub-id pub-id-type="pmid">36560523</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Issanov A, Karim ME, Aimagambetova G, et al. Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011&#x02013;2018). Vaccines (Basel). 2022;10(12):2113.<pub-id pub-id-type="pmid">36560523</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease</article-title><source>Front Cardiovasc Med</source><year>2022</year><volume>9</volume><fpage>952953</fpage><pub-id pub-id-type="doi">10.3389/fcvm.2022.952953</pub-id><pub-id pub-id-type="pmid">36172591</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">He L, Xie X, Xue J, et al. Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease. Front Cardiovasc Med. 2022;9:952953.<pub-id pub-id-type="pmid">36172591</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inflammatory burden index: associations between osteoarthritis and all-cause mortality among individuals with osteoarthritis</article-title><source>BMC Public Health</source><year>2024</year><volume>24</volume><issue>1</issue><fpage>2203</fpage><pub-id pub-id-type="doi">10.1186/s12889-024-19632-1</pub-id><pub-id pub-id-type="pmid">39138465</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Xiong Z, Xu W, Wang Y, et al. Inflammatory burden index: associations between osteoarthritis and all-cause mortality among individuals with osteoarthritis. BMC Public Health. 2024;24(1):2203.<pub-id pub-id-type="pmid">39138465</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>SM</given-names></name><name><surname>Hern&#x000e1;n</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Dietary intakes of fat and risk of Parkinson's disease</article-title><source>Am J Epidemiol</source><year>2003</year><volume>157</volume><issue>11</issue><fpage>1007</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1093/aje/kwg073</pub-id><pub-id pub-id-type="pmid">12777364</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Chen H, Zhang SM, Hern&#x000e1;n MA, et al. Dietary intakes of fat and risk of Parkinson&#x02019;s disease. Am J Epidemiol. 2003;157(11):1007&#x02013;14.<pub-id pub-id-type="pmid">12777364</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>HF</given-names></name><etal/></person-group><article-title>Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications</article-title><source>Diabetes Care</source><year>2012</year><volume>35</volume><issue>5</issue><fpage>1047</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.2337/dc11-1511</pub-id><pub-id pub-id-type="pmid">22432112</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Sun Y, Chang YH, Chen HF, et al. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care. 2012;35(5):1047&#x02013;9.<pub-id pub-id-type="pmid">22432112</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Kip</surname><given-names>E</given-names></name><name><surname>Parr-Brownlie</surname><given-names>LC</given-names></name></person-group><article-title>Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease</article-title><source>Ageing Res Rev</source><year>2022</year><volume>78</volume><fpage>101618</fpage><pub-id pub-id-type="doi">10.1016/j.arr.2022.101618</pub-id><pub-id pub-id-type="pmid">35395416</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Kip E, Parr-Brownlie LC. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson&#x02019;s disease. Ageing Res Rev. 2022;78:101618.<pub-id pub-id-type="pmid">35395416</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><etal/></person-group><article-title>A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank</article-title><source>Metabolism</source><year>2023</year><volume>146</volume><fpage>155643</fpage><pub-id pub-id-type="doi">10.1016/j.metabol.2023.155643</pub-id><pub-id pub-id-type="pmid">37380018</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">He P, Zhang Y, Ye Z, et al. A healthy lifestyle, Life&#x02019;s Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank. Metabolism. 2023;146: 155643.<pub-id pub-id-type="pmid">37380018</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Petermann-Rocha</surname><given-names>F</given-names></name><name><surname>Deo</surname><given-names>S</given-names></name><name><surname>Lyall</surname><given-names>D</given-names></name><etal/></person-group><article-title>Association Between the AHA Life's Essential 8 Score and Incident All-Cause Dementia: A Prospective Cohort Study from UK Biobank</article-title><source>Curr Probl Cardiol</source><year>2023</year><volume>48</volume><issue>11</issue><fpage>101934</fpage><pub-id pub-id-type="doi">10.1016/j.cpcardiol.2023.101934</pub-id><pub-id pub-id-type="pmid">37422047</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Petermann-Rocha F, Deo S, Lyall D, et al. Association Between the AHA Life&#x02019;s Essential 8 Score and Incident All-Cause Dementia: A Prospective Cohort Study from UK Biobank. Curr Probl Cardiol. 2023;48(11):101934.<pub-id pub-id-type="pmid">37422047</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Pajares M, I Rojo A, Manda G, Bosc&#x000e1; L, Cuadrado A. Inflammation in Parkinson's disease: mechanisms and therapeutic implications. Cells. 2020;9(7):1687. 10.3390/cells9071687.</mixed-citation></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Henein</surname><given-names>MY</given-names></name><name><surname>Vancheri</surname><given-names>S</given-names></name><name><surname>Longo</surname><given-names>G</given-names></name><etal/></person-group><article-title>The Role of Inflammation in Cardiovascular Disease</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>21</issue><fpage>12906</fpage><pub-id pub-id-type="doi">10.3390/ijms232112906</pub-id><pub-id pub-id-type="pmid">36361701</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Henein MY, Vancheri S, Longo G, et al. The Role of Inflammation in Cardiovascular Disease. Int J Mol Sci. 2022;23(21):12906.<pub-id pub-id-type="pmid">36361701</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Mirzaei</surname><given-names>H</given-names></name><name><surname>Guidi</surname><given-names>N</given-names></name><etal/></person-group><article-title>Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan</article-title><source>Nat Metab</source><year>2021</year><volume>3</volume><issue>10</issue><fpage>1342</fpage><lpage>1356</lpage><pub-id pub-id-type="doi">10.1038/s42255-021-00469-6</pub-id><pub-id pub-id-type="pmid">34650272</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Mishra A, Mirzaei H, Guidi N, et al. Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan. Nat Metab. 2021;3(10):1342&#x02013;56.<pub-id pub-id-type="pmid">34650272</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Jim&#x000e9;nez</surname><given-names>CA</given-names></name><name><surname>Gait&#x000e1;n-Vaca</surname><given-names>DM</given-names></name><name><surname>Echeverria</surname><given-names>V</given-names></name><etal/></person-group><article-title>Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View</article-title><source>Mol Neurobiol</source><year>2017</year><volume>54</volume><issue>9</issue><fpage>7096</fpage><lpage>7115</lpage><pub-id pub-id-type="doi">10.1007/s12035-016-0193-8</pub-id><pub-id pub-id-type="pmid">27796748</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Martin-Jim&#x000e9;nez CA, Gait&#x000e1;n-Vaca DM, Echeverria V, et al. Relationship Between Obesity, Alzheimer&#x02019;s Disease, and Parkinson&#x02019;s Disease: an Astrocentric View. Mol Neurobiol. 2017;54(9):7096&#x02013;115.<pub-id pub-id-type="pmid">27796748</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Bousquet</surname><given-names>M</given-names></name><name><surname>St-Amour</surname><given-names>I</given-names></name><name><surname>Vandal</surname><given-names>M</given-names></name><etal/></person-group><article-title>High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice</article-title><source>Neurobiol Dis</source><year>2012</year><volume>45</volume><issue>1</issue><fpage>529</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2011.09.009</pub-id><pub-id pub-id-type="pmid">21971528</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Bousquet M, St-Amour I, Vandal M, et al. High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice. Neurobiol Dis. 2012;45(1):529&#x02013;38.<pub-id pub-id-type="pmid">21971528</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Alarcon</surname><given-names>G</given-names></name><name><surname>Roco</surname><given-names>J</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name><etal/></person-group><article-title>High fat diet-induced metabolically obese and normal weight rabbit model shows early vascular dysfunction: mechanisms involved</article-title><source>Int J Obes (Lond)</source><year>2018</year><volume>42</volume><issue>9</issue><fpage>1535</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.1038/s41366-018-0020-6</pub-id><pub-id pub-id-type="pmid">29445240</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Alarcon G, Roco J, Medina M, et al. High fat diet-induced metabolically obese and normal weight rabbit model shows early vascular dysfunction: mechanisms involved. Int J Obes (Lond). 2018;42(9):1535&#x02013;43.<pub-id pub-id-type="pmid">29445240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>CJ</given-names></name><name><surname>Allison</surname><given-names>M</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association</article-title><source>Circulation</source><year>2014</year><volume>130</volume><issue>7</issue><fpage>593</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1161/CIR.0000000000000071</pub-id><pub-id pub-id-type="pmid">25098323</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Rodriguez CJ, Allison M, Daviglus ML, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593&#x02013;625.<pub-id pub-id-type="pmid">25098323</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Ascherio</surname><given-names>A</given-names></name><name><surname>Schwarzschild</surname><given-names>MA</given-names></name></person-group><article-title>The epidemiology of Parkinson's disease: risk factors and prevention</article-title><source>Lancet Neurol</source><year>2016</year><volume>15</volume><issue>12</issue><fpage>1257</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(16)30230-7</pub-id><pub-id pub-id-type="pmid">27751556</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Ascherio A, Schwarzschild MA. The epidemiology of Parkinson&#x02019;s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257&#x02013;72.<pub-id pub-id-type="pmid">27751556</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Cardiovascular Health and Life Expectancy Among Adults in the United States</article-title><source>Circulation</source><year>2023</year><volume>147</volume><issue>15</issue><fpage>1137</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.122.062457</pub-id><pub-id pub-id-type="pmid">37036905</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Ma H, Wang X, Xue Q, et al. Cardiovascular Health and Life Expectancy Among Adults in the United States. Circulation. 2023;147(15):1137&#x02013;46.<pub-id pub-id-type="pmid">37036905</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Cerri</surname><given-names>S</given-names></name><name><surname>Mus</surname><given-names>L</given-names></name><name><surname>Blandini</surname><given-names>F</given-names></name></person-group><article-title>Parkinson's Disease in Women and Men: What's the Difference?</article-title><source>J Parkinsons Dis</source><year>2019</year><volume>9</volume><issue>3</issue><fpage>501</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.3233/JPD-191683</pub-id><pub-id pub-id-type="pmid">31282427</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Cerri S, Mus L, Blandini F. Parkinson&#x02019;s Disease in Women and Men: What&#x02019;s the Difference? J Parkinsons Dis. 2019;9(3):501&#x02013;15.<pub-id pub-id-type="pmid">31282427</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Atterling Brolin</surname><given-names>K</given-names></name><name><surname>Schaeffer</surname><given-names>E</given-names></name><name><surname>Kuri</surname><given-names>A</given-names></name><etal/></person-group><article-title>Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications</article-title><source>Mov Disord</source><year>2024</year><pub-id pub-id-type="doi">10.1002/mds.30067</pub-id><pub-id pub-id-type="pmid">39601461</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Atterling Brolin K, Schaeffer E, Kuri A, et al. Environmental Risk Factors for Parkinson&#x02019;s Disease: A Critical Review and Policy Implications. Mov Disord. 2024. 10.1002/mds.30067.<pub-id pub-id-type="pmid">39601461</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>XT</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cardiovascular Health Score and Atherosclerotic Cardiovascular Disease in the Million Veteran Program</article-title><source>JAMA Netw Open</source><year>2024</year><volume>7</volume><issue>12</issue><fpage>e2447902</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.47902</pub-id><pub-id pub-id-type="pmid">39641929</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Nguyen XT, Li Y, Gong Y, et al. Cardiovascular Health Score and Atherosclerotic Cardiovascular Disease in the Million Veteran Program. JAMA Netw Open. 2024;7(12):e2447902.<pub-id pub-id-type="pmid">39641929</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzel</surname><given-names>S</given-names></name><name><surname>Berg</surname><given-names>D</given-names></name><name><surname>Gasser</surname><given-names>T</given-names></name><etal/></person-group><article-title>Update of the MDS research criteria for prodromal Parkinson's disease</article-title><source>Mov Disord</source><year>2019</year><volume>34</volume><issue>10</issue><fpage>1464</fpage><lpage>1470</lpage><pub-id pub-id-type="doi">10.1002/mds.27802</pub-id><pub-id pub-id-type="pmid">31412427</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Heinzel S, Berg D, Gasser T, et al. Update of the MDS research criteria for prodromal Parkinson&#x02019;s disease. Mov Disord. 2019;34(10):1464&#x02013;70.<pub-id pub-id-type="pmid">31412427</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>LV</given-names></name><name><surname>Lang</surname><given-names>AE</given-names></name></person-group><article-title>Parkinson's disease</article-title><source>Lancet</source><year>2015</year><volume>386</volume><issue>9996</issue><fpage>896</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)61393-3</pub-id><pub-id pub-id-type="pmid">25904081</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Kalia LV, Lang AE. Parkinson&#x02019;s disease. Lancet. 2015;386(9996):896&#x02013;912.<pub-id pub-id-type="pmid">25904081</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Lebouvier</surname><given-names>T</given-names></name><name><surname>Neunlist</surname><given-names>M</given-names></name><name><surname>Bruley des Varannes</surname><given-names>S</given-names></name><etal/></person-group><article-title>Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>9</issue><fpage>e12728</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0012728</pub-id><pub-id pub-id-type="pmid">20856865</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Lebouvier T, Neunlist M, Bruley des Varannes S, et al. Colonic biopsies to assess the neuropathology of Parkinson&#x02019;s disease and its relationship with symptoms. PLoS One. 2010;5(9):e12728.<pub-id pub-id-type="pmid">20856865</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>